Netherlands · 
Who invested in UniQure?
UniQure's investors include Hercules Technology Growth Capital, Coller Capital and Chiesi Pharmaceuticals.
2014
$58MGrowth$20MDebtNetherlands · Funded startup
Who invested in UniQure
2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$78Mraised across 2 rounds since 2013, from 2 sources
$58MGrowth$20MDebt
- Latest round
- Debt, $20MJul 2014
- Biggest round
- $58MGrowth · Jul 2013
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Growth, $58M Jul 2013
- Biggest round
- $58M Growth · Jul 2013
- Between rounds
- 12 months from the last two
The rounds
- Jul 2014
- Jul 2013
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Hercules Technology Growth CapitalInvestment firm1round
Chiesi Pharmaceuticalsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists UniQure as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about UniQure
How much has UniQure raised?
UniQure has raised $78M across 2 rounds since 2013.
When did UniQure last raise?
UniQure's most recent round was a Debt of $20M in Jul 2014.
What was UniQure's biggest round?
UniQure's largest round on record is $58M (Growth), in Jul 2013.
Who backed UniQure first?
UniQure's first round on record, in Jul 2013, was backed by Coller Capital and Chiesi Pharmaceuticals.
What stage is UniQure at?
UniQure's latest named round is a Debt, in Jul 2014.
Where is UniQure based?
UniQure is based in the Netherlands.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.